Stella, a leader in comprehensive treatment for post traumatic stress, anxiety, stress, depression, traumatic brain injury, and Long COVID, today announced a new growth equity round of $7 million. The capital raise will be used to advance Stella’s industry leading mental health research and open locations across the US and abroad.
Stella, a Sterling Partners (“Sterling”) portfolio company, also unveiled its new flagship facility in Chicago, which will serve as a hub for innovative treatments, research, and medical training – including hosting clinical trials and uncovering effective, science-backed treatment protocols and methodologies.
Read the full press release here.